Is plasma soluble CD36 associated with cardiovascular risk factors in early onset coronary artery disease patients?

References

• Ren Y, Silverstein RL, Allen J, Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995;181:1857–62.
   PubMed Web of Science ®Google Scholar
• Murphy-Ullrich JE, Schultz-Cherry S, Höök M. Transforming growth factor-β complexes with thrombospondin. Mol Biol Cell 1992;3:181–8.
   PubMed Web of Science ®Google Scholar
• Nicholson A, Pearce SFA, Silverstein RL. Oxidized LDL binds to CD36 on human monocyte–derived macrophages and transfected cell lines: evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol 1995;15:269–75.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Nozaki S, Nishida M, Yakub JM, Tomiyama Y, Nakata A, Matsumoto K, Funahashi T, Kameda-Takemura K, Kurata Y, Yamashita S, Matsuzawa Y. Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 1998;18:1350–7.
   PubMed Web of Science ®Google Scholar
• Huh HY, Pearce SFA, Yesner LM, Schindler JL, Silverstein RL. Regulated expression of CD36 during monocyte to macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996;87:2020–8.
   PubMed Web of Science ®Google Scholar
• Collot-Teixeira S, Martin J, McDermott-Roe C, Poston R, McGregor JL. CD36 and macrophages in atherosclerosis. Cardiovasc Res 2007;75:468–77.
   PubMed Web of Science ®Google Scholar
• Tuomisto TT, Riekkinen MS, Viita H, Levonen AL, Yla-Herttuala S. Analysis of gene and protein expression during monocyte-macrophage differentiation and cholesterol loading-cDNA and protein array study. Atherosclerosis 2005;180:283–91.
   PubMed Web of Science ®Google Scholar
• An P, Freedman BI, Hanis CL, Chen YD, Weder AB, Schork NJ, Boerwinkle E, Province MA, Hsiung CA, Wu X, Quertermous T, Rao DC. Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis. Diabetes 2005;54:909–14.
   PubMed Web of Science ®Google Scholar
• Malhotra A, Elbein SC, Ng MC, Duggirala R, Arya R, Imperatore G, Adeyemo A, Pollin TI, Hsueh WC, Chan JC, Rotimi C, Hanson RL, Hasstedt SJ, Wolford JK. Meta- analysis of genome-wide linkage studies of quantitative lipid traits in families ascertained for type 2 diabetes. Diabetes 2007;56:890–6.
   PubMed Web of Science ®Google Scholar
• Love-Gregory L, Sherva R, Sun L, Wasson J, Schappe T, Doria A, Rao DC, Hunt SC, Klein S, Neuman RJ, Permutt MA, Abumrad NA. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet 2008;17:1695–704.
   PubMed Web of Science ®Google Scholar
• Love-Gregory L, Sherva R, Sun L, Wasson J, Schappe T, Doria A, Rao DC, Hunt SC, Klein S, Neuman RJ, Permutt MA, Abumrad NA. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum Mol Genet 2011;20:193–201.
   PubMed Web of Science ®Google Scholar
• Gratchev A, Sobenin I, Orekhov A, Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases. Immunobiology 2012;217:476–82.
   PubMed Web of Science ®Google Scholar
• Mosig S, Rennert K, Krause S, Kzhyshkowska J, Neunubel K, Heller R, Funke H. Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14 + CD16+ monocytes in detoxification of oxidized LDL. FASEB J 2009;23:866–74.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Murugesan G, Chen K, Zhang L, Wang Q, Febbraio M, Anselmo RM, Marchant K, Barnard J, Silverstein RL. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms. Blood 2011;117:6355–66.
   PubMed Web of Science ®Google Scholar
• Handberg A, Levin K, Hojlund K, Beck-Nielsen H. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance. Circulation 2006;114:1169–76.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868–74.
   PubMed Web of Science ®Google Scholar
• Nicholson AC, Febbraio M, Han J, Silverstein RL, Hajjar DP. CD36 in atherosclerosis. The role of a class B macro- phage scavenger receptor. Ann NY Acad Sci 2000;902: 128–31.
   PubMed Web of Science ®Google Scholar
• Fernández-Real JM, Handberg A, Ortega F, Højlund K, Vendrell J, Ricart W. Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance. J Nutr Biochem 2009;20:477–84.
   PubMed Web of Science ®Google Scholar
• Takamura T, Sakurai M, Ota T, Ando H, Honda M, Kaneko S. Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients. Diabetologia 2004;47:638–47.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998;93:241–52.
   PubMed Web of Science ®Google Scholar
• Glintborg D, Højlund K, Andersen M, Henriksen JE, Beck-Nielsen, H, Handberg A. Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment. Diabetes Care 2008;31:328–34.
   PubMed Web of Science ®Google Scholar
• Handberg A, Norberg M, Stenlund H, Hallmans G, Attermann J, Eriksson JW. Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk. J Clin Endocrinol Metab 2010;95:1939–46.
   PubMed Web of Science ®Google Scholar
• Alkhatatbeh MJ, Mhaidat NM, Enjeti AK, Lincz LF, Thorne RF. The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles. J Thromb Haemost 2011;9:844–51.
   PubMed Web of Science ®Google Scholar
• Koonen DP, Jensen MK, Handberg A. Soluble CD36 – a marker of the (pathophysiological) role of CD36 in the metabolic syndrome? Arch Physiol Biochem 2011;117: 57–63.
   PubMedGoogle Scholar
• Rać ME, Suchy J, Kurzawski G, Kurlapska A, Safranow K, Rać M, Sagasz-Tysiewicz D, Krzystolik A, Poncyljusz W, Jakubowska K, Olszewska M, Krupa B, Chlubek D. Polymorphism of the CD36 gene and cardiovascular risk factors in patients with coronary artery disease manifested at a young age. Biochem Genet 2012;50:103–11.
   PubMed Web of Science ®Google Scholar
• Rac M, Kurzawski G, Safranow K, Rac M, Sagasz-Tysiewicz D, Krzystolik A, Poncyljusz W, Olszewska M, Dawid G, Chlubek D. Association of CD36 gene polymorphisms with echo- and electrocardiographic parameters in patients with early onset coronary artery disease. Arch Med Sci 2013;9:640–50.
   PubMed Web of Science ®Google Scholar
• Rać ME, Safranow K, Rać M, Kurzawski G, Krzystolik A, Sagasz-Tysiewicz D, Jakubowska K, Poncyljusz W, Chlubek D. CD36 gene is associated with thickness of atheromatous plaque and ankle-brachial index in patients with early coronary artery disease. Kardiol Pol 2012;70:918–23.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450–8.
   PubMed Web of Science ®Google Scholar
• de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992;20:1251–60.
   PubMed Web of Science ®Google Scholar
• Lahiri DK, Schnabel B. DNA isolation by a rapid method from human blood samples: effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 1993;31:321–8.
   PubMed Web of Science ®Google Scholar
• Rać ME, Suchy J, Kurzawski G, Safranow K, Jakubowska K, Olszewska M, Garanty-Bogacka B, Rać M, Poncyljusz W, Chlubek D. Analysis of human CD36 gene sequence alterations in the oxidized low-density lipoprotein-binding region using denaturing high-performance liquid chromatography. Genet Test Mol Biomarkers 2010;14:551–7.
   PubMed Web of Science ®Google Scholar
• Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361–72.
   PubMed Web of Science ®Google Scholar
• Kaczmarek M. Estimation of the age at natural menopause in a population-based study of Polish women. Przegląd Menopauzalny 2007;2:77–82.
   Google Scholar
• Chmielewski M, Bragfors-Helin AC, Stenvinkel P, Lindholm B, Anderstam B. Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients. Clinica Chimica Acta 2010;411:2079–82.
   PubMed Web of Science ®Google Scholar
• Handberg A. Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. J Intern Med 2011;271: 294–304.
   PubMed Web of Science ®Google Scholar
• Chilongola J, Balthazary S, Mpina M, Mhando M, Mbugi E. CD36 deficiency protects against malarial anaemia in children by reducing Plasmodium falciparum-infected red blood cell adherence to vascular endothelium. Trop Med Int Health 2009;14:810–6.
   PubMed Web of Science ®Google Scholar
• Handberg A, Lopez-Bermejo A, Bassols J, Vendrell J, Ricart W, Fernandez-Real JM. Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men. Diab Vasc Dis Res 2009;6:15–20.
   PubMed Web of Science ®Google Scholar
• Handberg A, Højlund K, Gastaldelli A, Flyvbjerg A, Dekker JM, Petrie J, Piatti P, Beck-Nielsen H. Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. J Intern Med 2012;271:294–304.
   PubMed Web of Science ®Google Scholar
• Silverstein RL. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med 2009;76 Suppl 2:S27–30.
   PubMedGoogle Scholar
• Knøsgaard L, Thomsen SB, Støckel M, Vestergaard H, Handberg A. Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals. Nutr Diabetes 2014;4:e114.
   PubMed Web of Science ®Google Scholar
• Bernal-Lopez RM, Llorente-Cortes V, López-Carmona D, Mayas DM, Gomez-Huelgas R, Tinahones FJ, Badimon L. Modulation of human monocyte CD36 by type 2 diabetes mellitus and other atherosclerotic risk factors. Eur J Clin Invest 2011;41:854–62.
   PubMed Web of Science ®Google Scholar
• Mandosi E, Fallarino M, Gatti A, Carnovale A, Rossetti M, Lococo E, Buchetti B, Filetti S, Lenti L, Morano S. Atorvastatin downregulates monocyte CD36 expression, nuclear NFkappaB and TNFalpha levels in type 2 diabetes. J Atheroscler Thromb 2010;17:539–45.
   PubMed Web of Science ®Google Scholar
• Piechota M, Banaszewska A, Dudziak J, Slomczynski M, Plewa R. Highly upregulated expression of CD36 and MSR1 in circulating monocytes of patients with acute coronary syndromes. Protein J 2012;31:511–8.
   PubMed Web of Science ®Google Scholar
• Yong Y, Nagueh SF, Shimoni S, Shan K, He ZX, Reardon MJ, Letsou GV, Howell JF, Verani MS, Quiñones MA, Zoghbi WA. Deceleration time in ischemic cardiomyopathy: relation to echocardiographic and scintigraphic indices of myocardial viability and functional recovery after revascularization. Circulation 2001;103:1232–7.
   PubMed Web of Science ®Google Scholar
• Hall D, Mayosi BM, Rahman TJ, Avery PJ, Watkins HC, Keavney B. Common variation in the CD36 (fatty acid translocase) gene is associated with left-ventricular mass. J Hypertens 2011;29:690–5.
   PubMed Web of Science ®Google Scholar
• Lykkeboe S, Larsen AL, Handberg A. Lack of consistency between two commercial ELISAs and against an in-house ELISA for the detection of CD36 in human plasma. Clin Chem Lab Med 2012;50:1071–4.
   PubMed Web of Science ®Google Scholar
• Alkhatatbeh MJ, Enjeti AK, Acharya S, Thorne RF, Lincz LF. The origin of circulating CD36 in type 2 diabetes. Nutr Diabetes 2013;3:e59.
   PubMed Web of Science ®Google Scholar
• Liani R, Halvorsen B, Sestili S, Handberg A, Santilli F, Vazzana N, Formoso G, Aukrust P, Davì G. Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients. Free Radic Biol Med 2012;52:1318–24.
   PubMed Web of Science ®Google Scholar
• Handberg A, Skjelland M, Michelsen AE, Sagen EL, Krohg-Sørensen K, Russell D, Dahl A, Ueland T, Oie E, Aukrust P, Halvorsen B. Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability. Stroke 2008;39:3092–5.
   PubMed Web of Science ®Google Scholar